P1.04-26 EMT-Associated Response and Resistance to MEK Inhibitor and Immune Checkpoint Blockade Combinations in KRAS-Mutant NSCLC

Authors :: Limo Chen
Bertha Leticia Rodriguez
Jennifer A. Wargo
David H. Peng
Don L. Gibbons
Jared J. Fradette
Laura A. Gibson
Samrat T. Kundu
Pierre Olivier Gaudreau
Triparna Sen
C.M. Della Corte
Source :: Journal of Thoracic Oncology. 14:S449-S450
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
business.industry
MEK inhibitor
Mutant
Cancer research
medicine
KRAS
medicine.disease_cause
business
Immune checkpoint
Blockade

Full Text Access

Tools